| A | adenine |
| ACEI | angiotensine converting enzyme inhibitor |
| ADAM | a desintegrine and metalloproteinase |
| ADAMTS | a desintegrine and metalloproteinase with trombospondine motif |
| AF | atrial fibrillation |
| AP | activator protein |
| ApoE | apolipoprotein E |
| ARB | angiotensine receptor blocker |
| Asn | asparagine |
| AVM | arteriovenous malformations |
| BBB | blood–brain barrier |
| BNP | brain natriuretic peptide |
| BP | blood pressure |
| C | cytosine |
| CAA | cerebral amyloid angiopathy |
| CES | cardioembolic stroke |
| CI | cerebral ischemia |
| CT | computed tomography |
| Cys | cysteine |
| DHF | diastolic heart failure |
| DNA | deoxyrybonucleic acid |
| ECM | extracellular matrix |
| ECV | electrical cardioversion |
| EF | ejection fraction |
| EGF | epidermal growth factor |
| EGRF | epithelial growth factor |
| END | early neurological deterioration |
| ERK | extracellular signal-regulated kinase |
| ESUS | embolic stroke of undetermined source |
| FLAIR | fluid attenuated inversion recovery |
| G | guanine |
| GPI | glycosylophosphatydyloinosytol |
| HF | heart failure |
| HFrEF | heart failure with reduced ejection fraction |
| HT | hemorrhagic transformation |
| IS | ischemic stroke |
| LA | left atrium |
| LV | left ventricle |
| LVH | left ventricle hypertrophy |
| MAPK | mitogen activated protein |
| MCAO | middle cerebral artery occlusion |
| MMP | metalloproteinase |
| MRI | magnetic resonance imaging |
| mRNA | messenger ribonucleic acid |
| MT-MMP | membrane type metalloproteinase |
| NF-κB | nuclear factor κB |
| PWV | pulse wave velocity |
| RA | right atrium |
| RAA | right atrium appendage |
| RAAS | renine angiotensine aldosterone system |
| RAS | renine angiotensine system |
| RECK | Reversion Inducing Cysteine Rich Protein with Kazal motifs |
| RCT | randomized clinical trial |
| RNA | ribonucleic acid |
| ROCK | Rho-associated protein kinase |
| rtPA | recombinant tissue plasminogen activator |
| RWF | right atrium free wall |
| SR | sinus rhythm |
| T | tymine |
| T2DM | type 2 diabetes mellitus |
| TGF | transforming growth factor |
| TIA | transient ischemic attack |
| TIMP | tissue inhibitor of metalloproteinase |
| TRE | 12-O-tetradecanoylphorbol-13-acetate-responsive element |